NKGEN BIOTECH INC (NKGN) Stock Price, Quote, News and Overview
NASDAQ:NKGN - Nasdaq - US65488A1016 - Common Stock - Currency: USD
NKGN Quote, Performance and Key Statistics
NKGEN BIOTECH INC
NASDAQ:NKGN (2/12/2025, 3:08:09 PM)
0.598
+0.22 (+57.45%)
The current stock price of NKGN is 0.598 USD. In the past month the price decreased by -22.49%. In the past year, price decreased by -74.68%.
NKGN Latest News and Analysis
Keep an eye on the top gainers and losers in Wednesday's session.
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.
Traders are paying attention to the gapping stocks in Wednesday's session.
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Wednesday's pre-market session: top gainers and losers
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
NKGen Biotech Selected as Stalking Horse Bidder for NKMax
NKGen Biotech Selected as Stalking Horse Bidder for NKMax
Upon closing, the transaction would secure global IP rights for NKGen.NKGen and its partners can begin to commercialize troculeucel in Korea, Japan and...
NKGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19 | 339.73B | ||
| AMGN | AMGEN INC | 14.88 | 158.52B | ||
| GILD | GILEAD SCIENCES INC | 22.24 | 127.78B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1547.34 | 115.56B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.45 | 72.46B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.67B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.17B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.88B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.78B | ||
| NTRA | NATERA INC | N/A | 22.43B | ||
| BIIB | BIOGEN INC | 8.08 | 19.22B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.08 | 16.34B |
Related stock screener links
About NKGN
Company Profile
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. The company is headquartered in Santa Ana, California and currently employs 63 full-time employees. The company went IPO on 2021-05-21. The firm is focused on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapeutics. Its product candidates are based on a manufacturing and cryopreservation process, which produces SuperNK (SNK) cells. SNK cells can be produced in large quantities and cryopreserved, while maintaining high levels of cytotoxicity and activating receptor expression after thawing and reconstitution. The company is developing SNK01, an autologous natural killer (NK) cell therapy, for the treatment of neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). Its autologous NK cell therapy candidate has clinical trials in several therapeutic areas, including oncology and neurodegeneration. SNK02 is its allogeneic NK cell product candidate. The company is conducting clinical trials with its SNK cell therapy in patients with neurodegenerative disease (SNK01) and cancer (SNK02).
Company Info
NKGEN BIOTECH INC
3001 Daimler St,
Santa Ana CALIFORNIA US
Employees: 63
Company Website: https://nkgenbiotech.com/
Phone: 19493966830
NKGN FAQ
What is the stock price of NKGN?
The current stock price of NKGN is 0.598 USD.
What is the symbol for NKGEN BIOTECH INC stock?
The exchange symbol of NKGEN BIOTECH INC is NKGN and it is listed on the Nasdaq exchange.
On which exchange is NKGN stock listed?
NKGN stock is listed on the Nasdaq exchange.
Is NKGN a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NKGN, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NKGN.
Does NKGN stock pay dividends?
NKGN does not pay a dividend.
When does NKGN stock report earnings?
NKGN will report earnings on 2025-04-14.
What is the Price/Earnings (PE) ratio of NKGN?
NKGN does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.71).
What is the Short Interest ratio of NKGN stock?
The outstanding short interest for NKGN is 2.66% of its float.
NKGN Technical Analysis
NKGN Financial Highlights
Over the last trailing twelve months NKGN reported a non-GAAP Earnings per Share(EPS) of -4.71. The EPS decreased by -50.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -564.01% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |